Evidence map›Paper›PMID 37110368›Full record

ArticleMicroorganisms2023

Green Biofabrication of Silver Nanoparticles of Potential Synergistic Activity with Antibacterial and Antifungal Agents against Some Nosocomial Pathogens.

Fatimah O Al-Otibi, Mohamed Taha Yassin, Abdulaziz A Al-Askar, Khalid Maniah

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Green Synthesis of Silver Nanoparticles Using Extracts ofIndian journal of microbiology · 2024
    Article
  13. Article
  14. Medicine and pharmacy reports · 2024
    Article
  15. Article
  16. Article
  17. The Green Synthesis of Silver Nanoparticles fromPathogens (Basel, Switzerland) · 2023
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fatimah O Al-OtibiBotany and Microbiology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Mohamed Taha YassinBotany and Microbiology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-0997-8350
Abdulaziz A Al-AskarBotany and Microbiology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Khalid ManiahBotany and Microbiology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
King Saud University · SA

Funding

King Saud University IFKSURG-2-1554
6 · The paper itself

Abstract

Nosocomial bacterial and fungal infections are one of the main causes of high morbidity and mortality worldwide, owing to the high prevalence of multidrug-resistant microbial strains. Hence, the study aims to synthesize, characterize, and investigate the antifungal and antibacterial activity of silver nanoparticles (AgNPs) fabricated using

Indexed as

antimicrobialCamellia sinensisgreen synthesissilver nanomaterialssynergism

Identifiers

PMID37110368
PMCPMC10144991
OpenAlexW4362557429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.